Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Empagliflozin on Natriuresis and Volume Overload in Patients With Cirrhosis and Ascites

NCT05726032 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05726032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Empagliflozin on Natriuresis and Volume Overload in Patients With Cirrhosis and Ascites
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
September 11, 2023
Completion date
December 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver failure